Literature DB >> 16687478

Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients.

Eric E Smith1, Danielle G Buckley, Zaining Wu, Channakhone Saenphimmachak, Lucas R Hoffman, David A D'Argenio, Samuel I Miller, Bonnie W Ramsey, David P Speert, Samuel M Moskowitz, Jane L Burns, Rajinder Kaul, Maynard V Olson.   

Abstract

In many human infections, hosts and pathogens coexist for years or decades. Important examples include HIV, herpes viruses, tuberculosis, leprosy, and malaria. With the exception of intensively studied viral infections such as HIV/AIDs, little is known about the extent to which the clonal expansion that occurs during long-term infection by pathogens involves important genetic adaptations. We report here a detailed, whole-genome analysis of one such infection, that of a cystic fibrosis (CF) patient by the opportunistic bacterial pathogen Pseudomonas aeruginosa. The bacteria underwent numerous genetic adaptations during 8 years of infection, as evidenced by a positive-selection signal across the genome and an overwhelming signal in specific genes, several of which are mutated during the course of most CF infections. Of particular interest is our finding that virulence factors that are required for the initiation of acute infections are often selected against during chronic infections. It is apparent that the genotypes of the P. aeruginosa strains present in advanced CF infections differ systematically from those of "wild-type" P. aeruginosa and that these differences may offer new opportunities for treatment of this chronic disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16687478      PMCID: PMC1482519          DOI: 10.1073/pnas.0602138103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  A more sensitive plate assay for detection of protease production by Pseudomanas aeruginosa.

Authors:  P A Sokol; D E Ohman; B H Iglewski
Journal:  J Clin Microbiol       Date:  1979-04       Impact factor: 5.948

2.  Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis.

Authors:  Sang Sun Yoon; Robert F Hennigan; George M Hilliard; Urs A Ochsner; Kislay Parvatiyar; Moneesha C Kamani; Holly L Allen; Teresa R DeKievit; Paul R Gardner; Ute Schwab; John J Rowe; Barbara H Iglewski; Timothy R McDermott; Ronald P Mason; Daniel J Wozniak; Robert E W Hancock; Matthew R Parsek; Terry L Noah; Richard C Boucher; Daniel J Hassett
Journal:  Dev Cell       Date:  2002-10       Impact factor: 12.270

3.  Constitutive high expression of chromosomal beta-lactamase in Pseudomonas aeruginosa caused by a new insertion sequence (IS1669) located in ampD.

Authors:  Niels Bagge; Oana Ciofu; Morten Hentzer; Joan I A Campbell; Michael Givskov; Niels Høiby
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

4.  Identification, timing, and signal specificity of Pseudomonas aeruginosa quorum-controlled genes: a transcriptome analysis.

Authors:  Martin Schuster; C Phoebe Lostroh; Tomoo Ogi; E P Greenberg
Journal:  J Bacteriol       Date:  2003-04       Impact factor: 3.490

5.  An adenylate cyclase-controlled signaling network regulates Pseudomonas aeruginosa virulence in a mouse model of acute pneumonia.

Authors:  Roger S Smith; Matthew C Wolfgang; Stephen Lory
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

6.  The Bvg virulence control system regulates biofilm formation in Bordetella bronchiseptica.

Authors:  Yasuhiko Irie; Seema Mattoo; Ming H Yuk
Journal:  J Bacteriol       Date:  2004-09       Impact factor: 3.490

7.  Contribution of the MexXY multidrug transporter to aminoglycoside resistance in Pseudomonas aeruginosa clinical isolates.

Authors:  Mara L Sobel; Geoffrey A McKay; Keith Poole
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

8.  Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains.

Authors:  R E Hancock; L M Mutharia; L Chan; R P Darveau; D P Speert; G B Pier
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

9.  Avirulence and altered physiological properties of cystic fibrosis strains of Pseudomonas aeruginosa.

Authors:  M A Luzar; T C Montie
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

10.  Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis.

Authors:  A E Hollsing; M Granström; M L Vasil; B Wretlind; B Strandvik
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 11.677

View more
  611 in total

1.  Genotypic and phenotypic variation in Pseudomonas aeruginosa reveals signatures of secondary infection and mutator activity in certain cystic fibrosis patients with chronic lung infections.

Authors:  Ashley E Warren; Carla M Boulianne-Larsen; Christine B Chandler; Kami Chiotti; Evgueny Kroll; Scott R Miller; Francois Taddei; Isabelle Sermet-Gaudelus; Agnes Ferroni; Kathleen McInnerney; Michael J Franklin; Frank Rosenzweig
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

2.  Evolutionary dynamics of bacteria in a human host environment.

Authors:  Lei Yang; Lars Jelsbak; Rasmus Lykke Marvig; Søren Damkiær; Christopher T Workman; Martin Holm Rau; Susse Kirkelund Hansen; Anders Folkesson; Helle Krogh Johansen; Oana Ciofu; Niels Høiby; Morten O A Sommer; Søren Molin
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

3.  Ecological succession in long-term experimentally evolved biofilms produces synergistic communities.

Authors:  Steffen R Poltak; Vaughn S Cooper
Journal:  ISME J       Date:  2010-09-02       Impact factor: 10.302

Review 4.  The population genetics of antibiotic resistance: integrating molecular mechanisms and treatment contexts.

Authors:  R Craig MacLean; Alex R Hall; Gabriel G Perron; Angus Buckling
Journal:  Nat Rev Genet       Date:  2010-06       Impact factor: 53.242

5.  Evolutionary genomics of epidemic and nonepidemic strains of Pseudomonas aeruginosa.

Authors:  Jeremy R Dettman; Nicolas Rodrigue; Shawn D Aaron; Rees Kassen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-09       Impact factor: 11.205

6.  Unique lipid a modifications in Pseudomonas aeruginosa isolated from the airways of patients with cystic fibrosis.

Authors:  Robert K Ernst; Samuel M Moskowitz; Julia C Emerson; Gretchen M Kraig; Kristin N Adams; Megan D Harvey; Bonnie Ramsey; David P Speert; Jane L Burns; Samuel I Miller
Journal:  J Infect Dis       Date:  2007-08-22       Impact factor: 5.226

7.  Direct interaction between sensor kinase proteins mediates acute and chronic disease phenotypes in a bacterial pathogen.

Authors:  Andrew L Goodman; Massimo Merighi; Mamoru Hyodo; Isabelle Ventre; Alain Filloux; Stephen Lory
Journal:  Genes Dev       Date:  2009-01-15       Impact factor: 11.361

8.  Developing an international Pseudomonas aeruginosa reference panel.

Authors:  Anthony De Soyza; Amanda J Hall; Eshwar Mahenthiralingam; Pavel Drevinek; Wieslaw Kaca; Zuzanna Drulis-Kawa; Stoyanka R Stoitsova; Veronika Toth; Tom Coenye; James E A Zlosnik; Jane L Burns; Isabel Sá-Correia; Daniel De Vos; Jean-Paul Pirnay; Timothy J Kidd; David Reid; Jim Manos; Jens Klockgether; Lutz Wiehlmann; Burkhard Tümmler; Siobhán McClean; Craig Winstanley
Journal:  Microbiologyopen       Date:  2013-11-11       Impact factor: 3.139

9.  Rapid diversification of Pseudomonas aeruginosa in cystic fibrosis lung-like conditions.

Authors:  Alana Schick; Rees Kassen
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-01       Impact factor: 11.205

10.  Entropically driven aggregation of bacteria by host polymers promotes antibiotic tolerance in Pseudomonas aeruginosa.

Authors:  Patrick R Secor; Lia A Michaels; Anina Ratjen; Laura K Jennings; Pradeep K Singh
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.